Chemotherapy for Hodgkins Lymphoma
- Main drug regimen: ABVD (doxorubicin [adriamycin], bleomycin [Blenoxane], vinblastine , and dacarbazine [DTIC])
- Other drug regimens: MOPP ( methotrexate [Rheumatrex], vincristine [Vincasar PFS], prednisone , procarbazine [Matulane]) alone or alternating with ABVD or ABV, COPP, and ChlVPP (chlorambucil [Leukeran], vincristine, prednisone, and procarbazine)
- Bone marrow suppression resulting in infection
- Low white blood cell counts
- Low red blood cell counts
- Low platelet counts
- Hair loss
- Appetite loss
- Taste changes
- Nausea and vomiting
- Inflammation and sores in the mouth, throat, and esophagus
- Reproductive and sexuality problems and hormonal changes, such as hypogonadism
- Heart damage
- Nervous system changes
- Lung damage
- Liver damage
- Kidney and urinary system damage
Hodgkin disease. American Cancer Society website. Available at: http://www.cancer.org/cancer/hodgkindisease/index . Accessed April 24, 2009.
Hodgkin lymphoma. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/types/hodgkin . Accessed April 24, 2009.
- Reviewer: Mohei Abouzied, MD
- Review Date: 10/2012 -
- Update Date: 03/18/2013 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.